• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Perinatol The Relationship Between Status at Presentation and Outcomes Among Pregnant Women With COVID-19

tetano

Editor, Senior Moderator
Am J Perinatol


. 2020 May 19.
doi: 10.1055/s-0040-1712164. Online ahead of print.
The Relationship Between Status at Presentation and Outcomes Among Pregnant Women With COVID-19


Viktoriya London[SUP] 1 [/SUP], Rodney McLaren Jr[SUP] 1 [/SUP], Fouad Atallah[SUP] 1 [/SUP], Catherine Cepeda[SUP] 1 [/SUP], Sandra McCalla[SUP] 1 [/SUP], Nelli Fisher[SUP] 1 [/SUP], Janet L Stein[SUP] 1 [/SUP], Shoshana Haberman[SUP] 1 [/SUP], Howard Minkoff[SUP] 1 2 [/SUP]



Affiliations

Abstract

Objective: This study was aimed to compare maternal and pregnancy outcomes of symptomatic and asymptomatic pregnant women with novel coronavirus disease 2019 (COVID-19).
Study design: This is a retrospective cohort study of pregnant women with COVID-19. Pregnant women were divided into two groups based on status at admission, symptomatic or asymptomatic. All testing was done by nasopharyngeal swab using polymerase chain reaction (PCR) for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Initially, nasopharyngeal testing was performed only on women with a positive screen (symptoms or exposure) but subsequently, testing was universally performed on all women admitted to labor and delivery. Chi-square and Wilcoxon's rank-sum tests were used to compare outcomes between groups.
Results: Eighty-one patients were tested because of a positive screen (symptoms [n = 60] or exposure only [n = 21]) and 75 patients were universally tested (all asymptomatic). In total, there were 46 symptomatic women and 22 asymptomatic women (tested based on exposure only [n = 12] or as part of universal screening [n = 10]) with confirmed COVID-19. Of symptomatic women (n = 46), 27.3% had preterm delivery and 26.1% needed respiratory support while none of the asymptomatic women (n = 22) had preterm delivery or need of respiratory support (p = 0.007 and 0.01, respectively).
Conclusion: Pregnant women who presented with COVID19-related symptoms and subsequently tested positive for COVID-19 have a higher rate of preterm delivery and need for respiratory support than asymptomatic pregnant women. It is important to be particularly rigorous in caring for COVID-19 infected pregnant women who present with symptoms.
Key points: ? Respiratory support is often needed for women who present with symptoms.. ? Low rate of severe disease in women who present without symptoms.. ? There were no neonatal infections on day 0 of life..




Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
 
Back
Top Bottom